MDGL Open Interest
Madrigal Pharmaceuticals Inc (MDGL) had 14.06K open option contracts as of Nov 4, 2026: 9.62K calls and 4.44K puts. Open interest rose 4.3% over the past four weeks. The put/call open interest ratio is 0.46, so calls outnumber puts.
Open Interest by Strike
Showing results for MDGL, 2026-11-20(m), calls & puts
Open Interest Stats
Showing results for MDGL, 2026-11-20(m), calls & puts
| Call Open Interest Total | |
|---|---|
| Put Open Interest Total | |
| Open Interest Total | |
| Put-Call Open Interest Ratio |
Highest Open Interest Options
Showing results for MDGL, 2026-11-20(m), calls & puts
Open Interest Total by Expiry
Showing results for MDGL, 2026-11-20(m), calls & puts. View all expiries
Open Interest History
Showing daily totals for MDGL, all expirations, calls & puts. View full history
MDGL Open Interest FAQ
What is open interest?
Open interest is the number of option contracts that are open and not yet closed, exercised, or expired. The Options Clearing Corporation calculates it once a day from the previous day's trades, and it is published before the market opens.
How much open interest does MDGL have?
Madrigal Pharmaceuticals had 14.06K open option contracts as of Nov 4, 2026. Over the past 30 days, open interest averaged 13.2K contracts.
Is MDGL open interest rising or falling?
Open interest rose 4.3% over the past four weeks. It was 13.48K contracts on Oct 7, 2026. See the MDGL open interest history for a longer view.
What is the MDGL put/call open interest ratio?
The Madrigal Pharmaceuticals put/call open interest ratio was 0.46 as of Nov 4, 2026. Four weeks earlier it was 0.44.
What is Madrigal Pharmaceuticals Inc?
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver...